MFS
RPRX icon

Monetta Financial Services’s Royalty Pharma RPRX Stock Holding History

Monetta Financial Services’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Hold
30,000
– – 1.13% 25
2026
Q1 		$1.44M Hold
30,000
– – 1.12% 26
2025
Q4 		$1.16M Hold
30,000
– – 0.83% 38
2025
Q3 		$1.06M Hold
30,000
– – 0.74% 42
2025
Q2 		$1.08M Buy
+30,000
New +$994K 0.79% 42

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Monetta Financial Services's RPRX Position: Q2 2026 in Review

Monetta Financial Services held its Royalty Pharma (RPRX) position steady in Q2 2026 at 30,000 shares worth $1.68M. The position accounts for 1.13% of the portfolio, ranked #25.

Monetta Financial Services first reported a position in RPRX in Q2 2025 and has held it in 5 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Monetta Financial Services held 30,000 shares of Royalty Pharma worth $1.68M as of Q2 2026.
  • Monetta Financial Services left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up 1.13% of Monetta Financial Services's portfolio in Q2 2026, its #25 holding.
  • Monetta Financial Services first reported a position in Royalty Pharma in Q2 2025 and has held it in 5 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Monetta Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.